Oppenheimer Cuts Bioceres Crop Solutions (NASDAQ:BIOX) Price Target to $13.00

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective lowered by Oppenheimer from $16.00 to $13.00 in a report published on Monday morning, Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other equities research analysts have also recently issued reports about the company. Roth Capital upgraded Bioceres Crop Solutions to a “strong-buy” rating in a research note on Tuesday, July 2nd. Canaccord Genuity Group lowered their target price on shares of Bioceres Crop Solutions from $12.50 to $10.00 and set a “buy” rating for the company in a research note on Thursday, October 17th. Canaccord Genuity Group upgraded shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Lake Street Capital lowered their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Finally, Roth Mkm cut their target price on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $12.25.

Bioceres Crop Solutions Price Performance

Shares of Bioceres Crop Solutions stock opened at $7.26 on Monday. The company has a quick ratio of 0.91, a current ratio of 1.28 and a debt-to-equity ratio of 0.35. The company has a market cap of $455.91 million, a P/E ratio of 726.00 and a beta of 0.47. The firm’s 50 day moving average price is $8.76 and its 200-day moving average price is $10.41. Bioceres Crop Solutions has a 52-week low of $7.15 and a 52-week high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, September 9th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.23). Bioceres Crop Solutions had a return on equity of 0.93% and a net margin of 0.68%. The firm had revenue of $124.30 million during the quarter, compared to analysts’ expectations of $126.75 million. During the same period in the prior year, the firm posted ($0.06) earnings per share. On average, sell-side analysts predict that Bioceres Crop Solutions will post 0.39 EPS for the current fiscal year.

Institutional Trading of Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently made changes to their positions in BIOX. Wellington Management Group LLP grew its position in Bioceres Crop Solutions by 3.1% during the 4th quarter. Wellington Management Group LLP now owns 236,906 shares of the company’s stock worth $3,253,000 after purchasing an additional 7,096 shares during the period. Oppenheimer & Co. Inc. purchased a new position in Bioceres Crop Solutions during the first quarter valued at approximately $139,000. Lazard Asset Management LLC acquired a new position in Bioceres Crop Solutions in the first quarter valued at approximately $212,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new stake in Bioceres Crop Solutions in the 2nd quarter worth approximately $472,000. Finally, Oak Family Advisors LLC grew its stake in shares of Bioceres Crop Solutions by 1.9% during the 2nd quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock worth $728,000 after purchasing an additional 1,208 shares during the period. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.